e-learning
resources
European Respiratory Review
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults
Megan L. Crichton, Stefano Aliberti, James D. Chalmers
Source:
Eur Respir Rev, 28 (151) 180108; 10.1183/16000617.0108-2018
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Megan L. Crichton, Stefano Aliberti, James D. Chalmers. A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults. Eur Respir Rev, 28 (151) 180108; 10.1183/16000617.0108-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Efficacy of psychosocial intervention in COPD: a systematic review and meta-analysis
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs)
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Efficacy of pharmacotherapy for OSA in adults: a systematic review and network meta-analysis
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019
A systematic review of clinical trial registration in major respiratory journals 2010–2018
Source: Eur Respir J, 52 (6) 1801491; 10.1183/13993003.01491-2018
Year: 2018
Erdosteine is effective as a treatment for acute exacerbation of COPD: a systematic review of clinical trials
Source: International Congress 2017 – COPD management
Year: 2017
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019
Year: 2019
A systematic review of how patients value COPD outcomes
Source: Eur Respir J, 52 (1) 1800222; 10.1183/13993003.00222-2018
Year: 2018
Clinical effectiveness and models of pulmonary rehabilitation in low-resource-settings: a systematic review
Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation
Year: 2019
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019
Year: 2019
COPD mortality and exacerbations in the placebo group of clinical trials over two decades: a systematic review and meta-regression
Source: ERJ Open Res, 8 (1) 00261-2021; 10.1183/23120541.00261-2021
Year: 2022
How are recovery and recurrence of COPD exacerbations defined in observational studies? A systematic review
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Does pulmonary rehabilitation work in clinical practice? A review on selection and dropout in randomised controlled trials on pulmonary rehabilitation
Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease
Year: 2010
Clinical effectiveness of triple therapy in the management of COPD: A systematic review
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010
Pharmacists' interventions on clinical asthma outcomes: a systematic review
Source: Eur Respir J 2016; 47: 1134-1143
Year: 2016
Operational definitions of paediatric asthma used in epidemiological studies: A systematic review
Source: Virtual Congress 2020 – Worldwide respiratory disease across the full spectrum
Year: 2020
Emerging concepts in outcome assessment for COPD clinical trials
Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Year: 2007
The clear evidence for pulmonary rehabilitation in chronic lung disease - a review of the most important randomised controlled trials
Source: International Congress 2018 – PG14 The evolving world of pulmonary rehabilitation
Year: 2018
Providing reviews of evidence to people with chronic disease: controlled prospective study in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 29s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept